SHERIDAN, Wyo., Oct. 6, 2026 /PRNewswire/ — The global drug delivery devices market is projected to grow from USD 488.6 billion in 2026 to USD 698.2 billion by 2031, registering a CAGR of 7.4% during the forecast period (2026–2031), according to a new study by Wissen Research. Growth is being driven by rising prevalence of diabetes, respiratory disease, cancer, and other chronic conditions requiring continuous treatment, alongside growing use of biologics and peptide-based therapies that demand specialized administration systems. Expanding adoption of home healthcare and self-administration, combined with the rise of connected, smart drug delivery platforms, is reshaping how patients manage…